Pages that link to "Q80219157"
Jump to navigation
Jump to search
The following pages link to Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus (Q80219157):
Displaying 50 items.
- Clearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLE (Q26767511) (← links)
- Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases (Q26770257) (← links)
- Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus (Q26822662) (← links)
- Toll-like Receptors in Systemic Lupus Erythematosus: Potential Targets for Therapeutic Intervention (Q26865485) (← links)
- How the Innate Immune System Senses Trouble and Causes Trouble (Q27016140) (← links)
- Modelling clinical systemic lupus erythematosus: similarities, differences and success stories (Q28074217) (← links)
- Lupus pathobiology based on genomics (Q33364409) (← links)
- Pathway of Toll-Like Receptor 7/B Cell Activating Factor/B Cell Activating Factor Receptor Plays a Role in Immune Thrombocytopenia In Vivo (Q33396543) (← links)
- TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus (Q33902262) (← links)
- Serum autoantibodies in pristane induced lupus are regulated by neutrophil gelatinase associated lipocalin (Q33992328) (← links)
- Lupus nephritis: lessons from murine models (Q33998360) (← links)
- Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus (Q34017633) (← links)
- Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice (Q34114826) (← links)
- Yaa autoimmune phenotypes are conferred by overexpression of TLR7. (Q34356566) (← links)
- Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 binding (Q34647633) (← links)
- Genetic susceptibility to idiopathic membranous nephropathy in high-prevalence Area, Taiwan (Q34691828) (← links)
- Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy (Q35055978) (← links)
- TLR7, IFNγ, and T-bet: their roles in the development of ABCs in female-biased autoimmunity (Q35235610) (← links)
- Toll-like receptor activation by helminths or helminth products to alleviate inflammatory bowel disease (Q35420431) (← links)
- TLR7 induces anergy in human CD4( ) T cells (Q35551047) (← links)
- Mdm2 promotes systemic lupus erythematosus and lupus nephritis (Q35758450) (← links)
- Roles of B Cell-Intrinsic TLR Signals in Systemic Lupus Erythematosus. (Q35813976) (← links)
- Conditional deletion of caspase-8 in macrophages alters macrophage activation in a RIPK-dependent manner. (Q36168991) (← links)
- The critical role of toll-like receptors--From microbial recognition to autoimmunity: A comprehensive review. (Q36372737) (← links)
- B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice (Q36532226) (← links)
- Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block. (Q36551073) (← links)
- C1q Modulates the Response to TLR7 Stimulation by Pristane-Primed Macrophages: Implications for Pristane-Induced Lupus (Q36555765) (← links)
- In vivo TLR9 inhibition attenuates CpG-induced myocardial dysfunction (Q36830961) (← links)
- Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens. (Q36851869) (← links)
- Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease (Q36903244) (← links)
- Leukocytes in glomerular injury (Q36972471) (← links)
- Role of nucleic acid-sensing TLRs in diverse autoantibody specificities and anti-nuclear antibody-producing B cells (Q37059648) (← links)
- Scavenging nucleic acid debris to combat autoimmunity and infectious disease (Q37258447) (← links)
- Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. (Q37497786) (← links)
- Hepcidin induction by pathogens and pathogen-derived molecules is strongly dependent on interleukin-6 (Q37546397) (← links)
- Dendritic cells and macrophages in kidney disease (Q37581431) (← links)
- Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (Q37639733) (← links)
- Endosomal Toll-like receptors in autoimmunity: mechanisms for clinical diversity (Q37693713) (← links)
- The role of Toll-like receptors in renal diseases (Q37696961) (← links)
- Interferon-alpha and -beta in kidney inflammation (Q37710960) (← links)
- Targeting Toll-like receptors: emerging therapeutics? (Q37727910) (← links)
- TLR7-expressing cells comprise an interfollicular epidermal stem cell population in murine epidermis (Q37733130) (← links)
- Innate immune receptors and autophagy: implications for autoimmune kidney injury. (Q37739204) (← links)
- Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9. (Q37758263) (← links)
- Toll-like receptors and lupus nephritis. (Q37769432) (← links)
- Plasmacytoid dendritic cells in antiviral immunity and autoimmunity (Q37769441) (← links)
- Targeting Toll-like receptors for treatment of SLE (Q37795596) (← links)
- Toll-like receptor signaling pathways--therapeutic opportunities (Q37803540) (← links)
- Toll-like receptor modulators: a patent review (2006 – 2010) (Q37853197) (← links)
- Toll-like receptors as targets for immune disorders (Q37870273) (← links)